Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay

International Journal of Cancer

Volumn 131, Issue 9, 2012, Pages 2008-2015

  Von Tungeln, Linda S ^a   Doerge, Daniel R ^a   Gamboa Da Costa, Gonçalo ^a   Matilde Marques, M ^b   Witt, William M ^a   Koturbash, Igor ^a   Pogribny, Igor P ^a   Beland, Frederick A ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

acrylamide; glycidamide; tumorigenicity

Indexed keywords

ACRYLAMIDE; GLYCIDAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BODY WEIGHT; CANCER SURVIVAL; CARCINOGEN TESTING; CARCINOGENICITY; CODON; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENOTOXICITY; INDUCED MUTATION; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TOXICITY; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE H RAS; PERINATAL PERIOD; PRIORITY JOURNAL; SURVIVAL RATE;

ACRYLAMIDE; ADENOMA, LIVER CELL; ANIMALS; ANIMALS, NEWBORN; CARCINOGENICITY TESTS; CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; EPOXY COMPOUNDS; FEMALE; GENES, RAS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MUTATION; RANDOM ALLOCATION;

EID: 84865551745     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27493     Document Type: Article

References (50)

1. International Agency for Research on Cancer. Acrylamide. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Industrial Chemicals, vol. 60. Lyon: International Agency for Research on Cancer, 1994. 389-433.
2. Cosmetic Ingredient Review Expert Panel. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics. Int J Toxicol 2005; 24 (Suppl 2): 21-50.
3. Mottram DS, Wedzicha BL, Dodson AT,. Acrylamide is formed in the Maillard reaction. Nature 2002; 419: 448-9.
4. Stadler RH, Blank I, Varga N, Robert F, Hau J, Guy PA, Robert M-C, Riediker S,. Acrylamide from Maillard reaction products. Nature 2002; 419: 449-50.
5. Doerge DR, Young JF, Chen JJ, DiNovi MJ, Henry SH,. Using dietary exposure and physiologically based pharmacokinetic/pharmacodynamic modeling in human risk extrapolations for acrylamide toxicity. J Agric Food Chem 2008; 56: 6031-8.
6. Bergmark E,. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem Res Toxicol 1997; 10: 78-84. (Pubitemid 27044911)
7. Rice JM,. The carcinogenicity of acrylamide. Mutat Res 2005; 580: 3-20.
8. Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, Macdonald N, Clewell H, Allen B, Van Landingham C,. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit Rev Toxicol 2006; 36: 481-608. (Pubitemid 44396721)
9. 1 mice (drinking water study) NTP TR 575, Research Triangle Park, NC: National Toxicology Program, in press.
10. Erdreich LS, Friedman MA,. Epidemiologic evidence for assessing the carcinogenicity of acrylamide. Regul Toxicol Pharmacol 2004; 39: 150-7. (Pubitemid 38388198)
11. Mucci LA, Wilson KM,. Acrylamide intake through diet and human cancer risk. J Agric Food Chem 2008; 56: 6013-9.
12. Mucci LA, Adami H-O,. The plight of the potato: is dietary acrylamide a risk factor for human cancer? J Natl Cancer Inst 2009; 101: 618-21.
13. Hogervorst JGF, Schouten LJ, Konings EJM, Goldbohm RA, van den Brandt PA,. Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol Biomarkers Prev 2009; 18: 1663-6.
14. Larsson SC, Åkesson A, Wolk A,. Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 2009; 18: 1939-41.
15. Larsson SC, Håkansson N, Åkesson A, Wolk A,. Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women. Int J Cancer 2009; 124: 1196-9.
16. Schouten LJ, Hogervorst JGF, Konings EJM, Goldbohm RA, van den Brandt PA,. Dietary acrylamide intake and the risk of head-neck and thyroid cancers: results from the Netherlands cohort study. Amer J Epidemiol 2009; 170: 873-84.
17. Wilson KM, Mucci LA, Rosner BA, and, Willett WC,. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev 2010; 19: 2503-15.
18. Wirfält E, Paulsson B, Törnqvist M, Axmon A, Hagmar L,. Associations between estimated acrylamide intakes, and hemoglobin AA adducts in a sample from the Malmö Diet and Cancer cohort. Eur J Clin Nutr 2008; 62: 314-23. (Pubitemid 351356570)
19. Calleman CJ, Bergmark E, Costa LG,. Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. Chem Res Toxicol 1990; 3: 406-12. (Pubitemid 20342195)
20. Sumner SCJ, Fennell TR, Moore TA, Chanas B, Gonzalez F, Ghanayem BI,. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 1999; 12: 1110-6.
21. Ghanayem BI, McDaniel LP, Churchwell MI, Twaddle NC, Snyder R, Fennell TR, Doerge DR,. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol Sci 2005; 88: 311-8. (Pubitemid 41672140)
22. 14C]acrylamide. Carcinogenesis 1995; 16: 1161-5.
23. Gamboa da Costa G, Churchwell MI, Hamilton LP, Von Tungeln LS, Beland FA, Marques MM, Doerge DR,. DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem Res Toxicol 2003; 16: 1328-37. (Pubitemid 37315222)
24. Ghanayem BI, Witt KL, El-Hadri L, Hoffler U, Kissling GE, Shelby MD, Bishop JB,. Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect. Biol Reprod 2005; 72: 157-63. (Pubitemid 40013766)
25. Ghanayem BI, Witt KL, Kissling GE, Tice RR, Recio L,. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect. Mutat Res 2005; 578: 284-97. (Pubitemid 41395332)
26. Manjanatha MG, Aidoo A, Shelton SD, Bishop ME, McDaniel LP, Lyn-Cook LE, Doerge DR,. Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ Mol Mutagen 2006; 47: 6-17. (Pubitemid 43238019)
27. Mei N, McDaniel LP, Dobrovolsky VN, Guo X, Shaddock JG, Mittelstaedt RA, Azuma M, Shelton SD, McGarrity LJ, Doerge DR, Heflich RH,. The genotoxicity of acrylamide and glycidamide in Big Blue rats. Toxicol Sci 2010; 115: 412-21.
28. Wang R-S, McDaniel LP, Manjanatha MG, Shelton SD, Doerge DR, Mei N,. Mutagenicity of acrylamide and glycidamide in the testes of Big Blue mice. Toxicol Sci 2010; 117: 72-80.
29. 1/Tk mice treated neonatally with acrylamide or glycidamide. Int J Cancer 2009; 124: 2006-15.
30. McClain RM, Keller D, Casciano D, Fu P, MacDonald J, Popp J, Sagartz J,. Neonatal mouse model: review of methods and results. Toxicol Pathol 2001; 29 (Suppl): 128-37.
31. Wislocki PG, Bagan ES, Lu AYH, Dooley KL, Fu PP, Han-Hsu H, Beland FA, Kadlubar FF,. Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay. Carcinogenesis 1986; 7: 1317-22.
32. Twaddle NC, Churchwell MI, McDaniel LP, Doerge DR,. Autoclave sterilization produces acrylamide in rodent diets: implications for toxicity testing. J Agric Food Chem 2004; 52: 4344-9.
33. Flammang TJ, Von Tungeln LS, Kadlubar FF, Fu PP,. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay. Regul Toxicol Pharmacol 1997; 26: 230-40. (Pubitemid 27494297)
34. Fu PP, Von Tungeln LS, Yi P, Xia Q, Casciano DA, Flammang TJ, Kadlubar FF,. Neonatal mouse tumorigenicity bioassay. Drug Information J 1998; 32: 711-28. (Pubitemid 28380911)
35. Fu PP, Von Tungeln LS, Hammons GJ, McMahon G, Wogan G, Flammang TJ, Kadlubar FF,. Metabolic activation capacity of neonatal mice in relation to the neonatal mouse tumorigenicity bioassay. Drug Metab Rev 2000; 32: 241-66. (Pubitemid 30198561)
36. Mitchell KR, Warshawsky D,. Mutational analysis using enriched PCR and cycle sequencing. BioTechniques 1998; 24: 1028-31. (Pubitemid 28275143)
37. Cariello NF, Piegorsch WW, Adams WT, Skopek TR,. Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis 1994; 15: 2281-5.
38. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL,. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 1995; 101: 125-56.
39. 1 mice exposed to tetrafluoroethylene for two years. Toxicol Pathol 1998; 26: 646-50. (Pubitemid 28462716)
40. Sills RC, Boorman GA, Neal JE, Hong HL, Devereux TR,. Mutations in ras genes in experimental tumours of rodents. In:, McGregor DB, Rice JM, Venitt S,. eds. The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation. IARC Scientific Publications No. 146, Lyon: International Agency for Research on Cancer, 1999. 55-86.
41. Iida M, Iwata H, Inoue H, Enomoto M, Horie N, Takeishi, K., Correlation between Bcl-2 overexpression and H-ras mutation in naturally occurring hepatocellular proliferative lesions of the B6C3F1 mouse. Toxicol Sci 2000; 56: 297-302. (Pubitemid 30497498)
42. 1 mice following exposure to diethanolamine for 2 years. Chem Biol Interact 2003; 146: 251-61. (Pubitemid 37464854)
43. Jeannot E, Pogribny IP, Beland FA, Rusyn I,. Chronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells. Cancer Lett 2011; 301: 161-7.
44. Olstørn HBA, Paulsen JE, Alexander J,. Effects of perinatal exposure to acrylamide and glycidamide on intestinal tumorigenesis in Min/+ mice and their wild-type litter mates. Anticancer Res 2007; 27: 3855-64.
45. Besaratinia A, Pfeifer GP,. Weak yet distinct mutagenicity of acrylamide in mammalian cells. J Natl Cancer Inst 2003; 95: 889-96. (Pubitemid 36833880)
46. Besaratinia A, Pfeifer GP,. Genotoxicity of acrylamide and glycidamide. J Natl Cancer Inst 2004; 96: 1023-9. (Pubitemid 39162645)
47. Besaratinia A, Pfeifer GP,. DNA adduction and mutagenic properties of acrylamide. Mutat Res 2005; 580: 31-40.
48. 1 mouse. Proc Natl Acad Sci USA 1986; 83: 5825-9. (Pubitemid 16000605)
49. Dragani TA, Manenti G, Colombo BM, Falvella FS, Gariboldi M, Pierotti MA, Della Porta G,. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis. Oncogene 1991; 6: 333-8. (Pubitemid 21902681)
50. Watson MA, Devereux TR, Malarkey DE, Anderson MW, Maronpot RR,. H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. Carcinogenesis 1995; 16: 1705-10.